November 06, 2026

New study highlights the sensitivity of hiPSC-RPE cells for investigating retinal disease mechanisms

New study highlights the sensitivity of hiPSC-RPE cells for investigating retinal disease mechanisms

Researchers at Experimentica have demonstrated that human induced pluripotent stem cell-derived retinal pigment epithelium (hiPSC-RPE) cells provide a highly relevant in vitro model for studying oxidative stress-related retinal diseases, including age-related macular degeneration (AMD). The study showed that these cells closely resemble native human RPE tissue both morphologically and functionally, making them a valuable platform for preclinical research and drug development.

Oxidative stress-induced gene expression changes in hiPSC-RPE cells

A key focus of the study was to characterize gene expression changes triggered by oxidative stress. Using sodium iodate (NaIO3), a well-established RPE-specific stress inducer, researchers identified a distinct molecular response in hiPSC-RPE cells. The hiPSC-RPE model revealed robust oxidative stress-induced changes in gene expression, characterized by upregulation of VEGFA, HIF1A, TXN, CHAC1, and SLC7A11 and downregulation of TXNIP. Together, these findings demonstrate activation of pro-angiogenic and ferroptosis-associated pathways, highlighting the model’s suitability for studying retinal disease mechanisms and therapeutic targets.

ROS levels increased significantly before viability loss was observed

Notably, the hiPSC-RPE model detected substantial increases in reactive oxygen species (ROS) at low stress levels before any measurable loss of cell viability occurred. This sensitivity enables the identification of early molecular events preceding cell damage, providing a powerful tool for evaluating novel therapeutic interventions.

Activation of the thioredoxin system and ferroptosis-related gene expression

The study also demonstrated activation of the thioredoxin antioxidant system, which plays a central role in maintaining cellular redox balance. Increased TXN expression together with reduced TXNIP expression suggests that hiPSC-RPE cells mount a protective response against oxidative injury. At the same time, elevated VEGFA and HIF1A expression mirrors pathways implicated in pathological angiogenesis observed in wet age-related macular degeneration (AMD).

Importantly, the hiPSC-RPE model captured gene expression signatures linked to ferroptosis, a form of iron-dependent cell death increasingly associated with retinal degeneration. Upregulation of CHAC1 and SLC7A11 highlights the balance between cellular adaptation and pro-ferroptotic stress responses, providing additional biomarkers for therapeutic screening.

Overall, the findings establish hiPSC-RPE cells as a physiologically relevant and highly sensitive platform for studying oxidative stress, gene regulation, and disease pathways in the retina. The model offers significant opportunities for the development and testing of anti-VEGF therapies, gene-editing strategies, and other treatments targeting retinal diseases such as age-related macular degeneration (AMD).

View full article

Authors

Anni Kolehmainen, Robertas Čėsna, Olga Vergun, Dovilė Navickė, Giedrius Kalesnykas, Jenni J. Hakkarainen

Our latest News

discover more
Building Better Sandwich Immunoassays: A Toolbox for Biopharma Development Teams

Building Better Sandwich Immunoassays: A Toolbox for Biopharma Development Teams

Immunoassay development used to just mean getting a classic plate-based ELISA up and running. Today, that “standard” ELISA has exploded into many antibody pair-based formats, from homogeneous TR‑FRET assays to multiplexed MSD or Luminex panels—each with its own advantages and pitfalls. The data these assays generate is more robust than ever, but so is the […]

Lonza Signs Agreement to Acquire US CDMO Network from Merck KGaA, Darmstadt, Germany, and Significantly Expands its US Presence

Lonza Signs Agreement to Acquire US CDMO Network from Merck KGaA, Darmstadt, Germany, and Significantly Expands its US Presence

Basel, Switzerland, 3 November 2026 – Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced today that it has signed a definitive agreement to acquire five CDMO manufacturing sites in the US from Merck KGaA, Darmstadt, Germany at a total enterprise valuation in the low- to mid-triple-digit millions Swiss francs. The acquisition expands […]

New study highlights the sensitivity of hiPSC-RPE cells for investigating retinal disease mechanisms

New study highlights the sensitivity of hiPSC-RPE cells for investigating retinal disease mechanisms

Researchers at Experimentica have demonstrated that human induced pluripotent stem cell-derived retinal pigment epithelium (hiPSC-RPE) cells provide a highly relevant in vitro model for studying oxidative stress-related retinal diseases, including age-related macular degeneration (AMD). The study showed that these cells closely resemble native human RPE tissue both morphologically and functionally, making them a valuable platform […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp